Z-0877-2021 Class II Terminated

Recalled by Roche Molecular Systems, Inc. — Branchburg, NJ

FDA device recall Z-0877-2021 was initiated by Roche Molecular Systems, Inc. on November 23, 2020 and is designated Class II. Reason for recall: When a user creates a measurement tool annotation in the uPath Enterprise software version 1.1, the measurement value is incorrectly calculated when the measurement is viewed in "Split View" viewing m… The recall status is terminated (terminated May 22, 2023). Affected quantity: 27.

Recall Details

Product Type
Devices
Report Date
January 27, 2021
Initiation Date
November 23, 2020
Termination Date
May 22, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
27

Product Description

uPath software 1.1 and uPath software 1.1 IVD-INSW, Material numbers 08991871001 and 09077332001

Reason for Recall

When a user creates a measurement tool annotation in the uPath Enterprise software version 1.1, the measurement value is incorrectly calculated when the measurement is viewed in "Split View" viewing mode and the slides within the case are scanned at different magnifications.

Distribution Pattern

Domestic distribution to Maryland and Michigan. International distribution to France, Greece, Italy, Poland, Turkey, Brazil, India, and Singapore.

Code Information

version 1.1